Avsar.
AL

Healthcare · Pharmaceuticals

Alpa Laboratories Ltd (ALPA)

₹58.95

Mkt cap
₹125 Cr
P/E ratio
30.80
P/B
0.67
Div yield
0.00%
ROE
8.39%
ROCE
9.42%
EPS (TTM)
₹1.91
Book value
₹89
52W range
46–94
Sector
Healthcare

Price history

Previous close

Incorporated in 1988, Alpa Laboratories Ltd manufactures and sells Drugs and Chemicals [1]

NSE ALPABSE 532878
Health check
Cautious
ValuationFair
ProfitabilityWeak
GrowthModerate
TechnicalsBearish
52-week range
−37.19% from high
₹59
₹46+27.87% from low₹94
Current
₹58.95
Prev close
₹58.78
Day
+0.29%
Price performance
1D
+0.29%
1W
−0.44%
1M
−6.87%
3M
−13.77%
6M
+13.91%
1Y
−34.81%
YTD
−24.46%

Financials

Revenue, profit & margin
P/E ratio
30.8×
ALPA is 11% below the sector median of 34.6×
ALPA30.8×
Sector median34.6×
 Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Trend
Sales25.4332.3927.3123.6121.4424.9426.1539.9219.1126.2629.0531.4023.93
Expenses26.5729.0424.8820.1020.9121.6225.4139.7218.6828.5127.5427.8027.89
Operating Profit-1.143.352.433.510.533.320.740.200.43-2.251.513.60-3.96
OPM %-4.48%10.34%8.90%14.87%2.47%13.31%2.83%0.50%2.25%-8.57%5.20%11.46%-16.55%
Other Income4.472.953.553.985.166.918.802.4811.943.060.91-0.165.77
Interest0.020.020.020.290.050.050.090.020.050.030.030.150.11
Depreciation0.280.490.660.520.540.530.550.580.550.670.650.220.72
Profit before tax3.035.795.306.685.109.658.902.0811.770.111.743.070.98
Tax %0.00%0.00%14.91%46.71%0.00%20.31%0.00%201.92%0.00%0.00%9.20%55.05%0.00%
Net Profit3.035.794.513.555.107.698.90-2.1211.770.111.591.380.98
EPS in Rs1.442.752.141.692.423.654.23-1.015.590.050.760.660.47
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −2.40% · closed higher next day 0 of last 1
 Q1FY27
Broadcast13 Aug '26◦
Earnings day−2.40%
+1 day−3.23%
+5 days−4.71%
+15 days−4.77%
+30 days−10.08%
FilingXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Results analysis

Shareholding

as of Jun 2026
57.19%Promoter
Promoters57.19%
FIIs0.35%0.03
DIIs0.07%0.07
Public42.38%0.05
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,837.3034.904,40,8300.87%2,901+5.95%15,300+10.46%20.53%
Divi's Lab.₹9,375.0083.542,48,8770.32%902+65.50%3,080+27.80%21.97%
Torrent Pharma.₹4,840.0082.511,84,0980.79%566+5.79%4,921+54.85%15.19%
Zydus Lifesci.₹1,160.0023.771,15,7100.09%990−35.09%8,017+21.96%21.14%
Cipla₹1,394.5031.481,12,6560.93%786−39.19%7,119+2.33%15.49%
Laurus Labs₹1,954.0096.561,05,5770.10%362+125.49%2,026+29.10%17.76%
Aurobindo Pharma₹1,734.0026.3999,7710.23%1,032+28.11%9,150+16.30%12.86%
Alpa Laboratorie₹59.3530.761250.00%1−91.67%24+25.22%9.42%
Median: 158 Co.₹433.9034.562,2050.08%13+29.57%164+18.57%14.96%

Filings

Annual reports15
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022Annual Report 2021Annual Report 2020Annual Report 2019Annual Report 2018Annual Report 2017Annual Report 2016Annual Report 2015Annual Report 2014Annual Report 2013Annual Report 2012
Credit ratings6
Rating update 29 Aug 2025crisilRating update 29 Jun 2024crisilRating update 29 Apr 2023crisilRating update 26 Feb 2022crisilRating update 28 Dec 2020crisilRating update 25 Sep 2019crisil
Announcements5
Appointment of Company Secretary and Compliance Officer 17 Sep - Alpa Laboratories appoints Ms. Diksha Jaswani as Company Secretary-cum-Compliance Officer effective 17 September 2026.Reg. 34 (1) Annual Report. 7 SepFixes Book Closure For The Purpose Of AGM. 7 SepAnnouncement under Regulation 30 (LODR)-Change in Management 7 Sep - Radhika Biyani appointed Additional Independent Director from 5 Sept 2026; board committees reconstituted.Results For The Quarter Ended June 2026 13 Aug